Overview

Postpartum Hypertension Study

Status:
Not yet recruiting

Trial end date:
2024-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby.

Phase:

Phase 4

Details

Lead Sponsor:

Columbia University

Treatments:

Labetalol
Nifedipine